Stefan Schulte;Uwe Kalina;Michael Moses;Annette Feussner
发明人:
Stefan Schulte,Uwe Kalina,Michael Moses,Annette Feussner
申请号：
US14116491
公开号：
US20140161899A1
申请日:
2012.05.14
申请国别(地区):
US
年份:
2014
代理人:
摘要：
The instant invention provides a method to reduce adverse events caused by a pharmaceutical preparation derived from a plasma fraction wherein the method comprises contacting the plasma fraction with heparin or a heparin-like substance thereby reducing the activity of at least one activated serine proteaseper ml of the plasma fraction.
